Implications of clinical trial data sharing for medical writers

Author: Ross Joseph S.  

Publisher: Maney Publishing

ISSN: 2047-4814

Source: Medical Writing, Vol.22, Iss.1, 2013-03, pp. : 45-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Major clinical research funders are increasingly adopting policies supporting or mandating data sharing. These moves should improve the transparency and availability of clinical trial data and are likely to impact the work and responsibilities of medical writers. Medical writers are likely to play a prominent role in standardising policies and procedures and have the opportunity to lead the development of an efficient and feasible system for promoting clinical trial data sharing. These efforts will ensure that the research community can derive the full benefit from the enormous resources devoted to human clinical trial research and will help build patient trust in the research process.